Company intelligence / Profile preview

PharmInVivo

Saint-Ismier, Isère, France

Ownership: Private
Employees: ~10
Development stage: Other

Overview

PharmInVivo is a specialized Contract Research Organization (CRO) providing preclinical in vivo pharmacology services to the pharmaceutical and biotechnology industries. The company focuses on evaluating the efficacy and pharmacokinetics of drug candidates across several therapeutic areas, including oncology, inflammation, and central nervous system disorders. PharmInVivo offers customized experimental models and expert consultancy to accelerate the drug development process from lead optimization to candidate selection. Their services include proof-of-concept studies, dose-response evaluations, and mechanism of action analysis.

Therapeutic areas: OncologyImmunologyNeurology
Modalities: Small moleculeMonoclonal antibodyPeptidesBiologic
Industry: Contract Research Organization

Beyond the preview

Go deeper on PharmInVivo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PharmInVivo.

Explore the full profile